Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920049 · ClinicalTrials.gov registry record · Phase 1
Preventing Motor Vehicle Crashes Among Young Drivers: Evaluation of the Checkpoints Program Presented by the American Automobile Association
A Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 1
- Development phase
- 830
- Enrollment target
NCT00920049: Completed Phase 1 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00920049 is a Phase 1 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 830 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1283% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920049, a Phase 1 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 830 participants
- Enrollment target
Study Summary
Background: * Automobile crash risks are highest right after licensure and decline rapidly for about 6 months and then gradually for years, regardless of the amount of supervised practice driving or age at licensure. The only approaches to this problem that have demonstrated effectiveness are Graduated Driver Licensing (GDL) and parental management. * The Checkpoints Program consists of persuasive messages and materials designed to increase adoption of the Checkpoints Parent-Teen Driving Agreement and to improve parents' ability to set limits on higher-risk driving privileges for novice drivers. Researchers are interested in determining whether expanding the Checkpoints Program to an online version (instead of through the mail) can help improve parent limit-setting in connection with the program. Objectives: * To determine the feasibility and effectiveness of conducting an online version of the Checkpoints Program through American Automobile Association (AAA) clubs. * To test rates of parental intervention and limit-setting after participation in the Checkpoints Program. Eligibility: \- Parents whose teenage children are enrolled in AAA-affiliated driving schools. Design: * Parents with children at the permit stage of driver's education will be recruited through AAA clubs and will be asked to visit a designated Web site to sign up for the program. * Parents will provide consent and complete the baseline survey, and will be assigned to random groups to test different versions of the Checkpoints Program (the intervention or a control group Web site). * The intervention program will contain videos, regular e-mails, and newsletters on setting parental limits and information on specific teen driving risks. The control program will provide information on various topics related to the licensing procedure and safe driving, but no specific information on teen driving risks. * A follow-up assessment will be conducted 1 month after the teenager receives his or her licen
Interventions
- BEHAVIORAL Persuasion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 830 participants |
| Start Date | 2009-06-05 |
| Est. Completion | 2012-03-29 |
| Phase | Phase 1 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00920049 record still lists
NCT00920049 is an interventional study that assigns participants to a tested intervention. The registered 830 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (1283% higher).
The record links to 0 conditions, and to 1 intervention - of which Persuasion is the first listed.
NCT00920049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920049 about?
NCT00920049 is a clinical study titled "Preventing Motor Vehicle Crashes Among Young Drivers: Evaluation of the Checkpoints Program Presented by the American Automobile Association". Background: * Automobile crash risks are highest right after licensure and decline rapidly for about 6 months and then gradually for years, regardless of the amount of supervised practice driving or age at licensure. The only approaches to this problem that have demonstrated effectiveness are Gradu...
What is the current status of trial NCT00920049?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 830 participants. The study started on 2009-06-05. Estimated completion is 2012-03-29.
What interventions are being tested in trial NCT00920049?
The interventions under investigation include: Persuasion (BEHAVIORAL).
Who is sponsoring clinical trial NCT00920049?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00920049's enrollment target sits among peer trials
830 12th of 2000 higher than 1,989 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- NCT06868277 · 830 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
- NCT06910553 · 832 participants
IBD Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI